Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
inflammatory5866 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A14071 | 29602794 | Diabetes Care | Specific Hepatic Sphingolipids Relate to Insulin Resistance, Oxidative Stress, and Inflammation in Nonalcoholic Steatohepatitis. | 2018 | Details |
| A14081 | 29599925 | Oncotarget | A porcine placental extract prevents steatohepatitis by suppressing activation of macrophages and stellate cells in mice. | 2018 | Details |
| A14082 | 29599631 | Malays J Med Sci | The Effect of Amygdalin on Endoplasmic Reticulum (ER) Stress Induced Hepatic Steatosis in Mice. | 2018 | Details |
| A14090 | 29593815 | Arch Med Sci | Preventive effects of total saponins of Panax japonicus on fatty liver fibrosis in mice. | 2016 | Details |
| A14092 | 29592806 | J Biomed Sci | β-aminoisobutyric acid attenuates LPS-induced inflammation and insulin resistance in adipocytes through AMPK-mediated pathway. | 2018 | Details |
| A14097 | 29589386 | Endocrinol Metab (Seoul) | Association of Adipokines with Development and Progression of Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A14100 | 29587769 | Reprod Biol Endocrinol | Circulating osteopontin and its association with liver fat content in non-obese women with polycystic ovary syndrome: a case control study. | 2018 | Details |
| A14102 | 29584449 | Crit Rev Food Sci Nutr | Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials: Synbiotic supplementation and NAFLD. | 2018 | Details |
| A14104 | 29581157 | J Lipid Res | Regulation of mitochondrial trifunctional protein modulates nonalcoholic fatty liver disease in mice. | 2018 | Details |
| A14107 | 29579601 | Int J Cardiol | Circulating Interleukin-6 is a biomarker for coronary atherosclerosis in nonalcoholic fatty liver disease: Results from the Multi-Ethnic Study of Atherosclerosis. | 2018 | Details |
| A14122 | 29574534 | J Gastroenterol | To die or not to die: death signaling in nonalcoholic fatty liver disease. | 2018 | Details |
| A14124 | 29573006 | Hepatology | Ubiquitin-Specific Protease 4 Is an Endogenous Negative Regulator of Metabolic Dysfunctions in Nonalcoholic Fatty Liver Disease in Mice. | 2018 | Details |
| A14135 | 29569260 | Clin Exp Pharmacol Physiol | Down-regulation of microRNA-375 regulates adipokines and inhibits inflammatory cytokines by targeting AdipoR2 in non-alcoholic fatty liver disease. | 2018 | Details |
| A14141 | 29566909 | Best Pract Res Clin Gastroenterol | NAFLD, Helicobacter species and the intestinal microbiome. | 2017 | Details |
| A14144 | 29565153 | Nutr Hosp | Inflammatory cytokines and non-alcoholic fatty liver disease (NAFLD) in obese children and adolescents. | 2018 | Details |
| A14149 | 29563854 | Mediators Inflamm | Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A14150 | 29563328 | JCI Insight | Peroxisomal β-oxidation regulates whole body metabolism, inflammatory vigor, and pathogenesis of nonalcoholic fatty liver disease. | 2018 | Details |
| A14156 | 29560693 | Acta Gastroenterol Belg | Apoptosis and Disease Severity is Associated with Insulin Resistance in Non-alcoholic Fatty Liver Disease. | 2018 | Details |
| A14162 | 29557414 | J Gastrointestin Liver Dis | A Multi-strain Probiotic Reduces the Fatty Liver Index, Cytokines and Aminotransferase levels in NAFLD Patients: Evidence from a Randomized Clinical Trial. | 2018 | Details |
| A14172 | 29552625 | Cell Mol Gastroenterol Hepatol | Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2). | 2017 | Details |
| A14186 | 29544992 | Mol Aspects Med | Omega-3 fatty acids and non-alcoholic fatty liver disease: Evidence of efficacy and mechanism of action. | 2018 | Details |
| A14206 | 29526820 | Biochim Biophys Acta Mol Basis Dis | Benzbromarone aggravates hepatic steatosis in obese individuals. | 2018 | Details |
| A14210 | 29525610 | Nutr Res | Arctigenin protects against steatosis in WRL68 hepatocytes through activation of phosphoinositide 3-kinase/protein kinase B and AMP-activated protein kinase pathways. | 2018 | Details |
| A14216 | 29522534 | PLoS One | Niemann-Pick type C2 protein supplementation in experimental non-alcoholic fatty liver disease. | 2018 | Details |
| A14221 | 29519316 | Phytomedicine | CGplus, a standardized herbal composition ameliorates non-alcoholic steatohepatitis in a tunicamycin-induced mouse model. | 2018 | Details |
| A14229 | 29514661 | J Transl Med | Physiological and molecular effects of interleukin-18 administration on the mouse kidney. | 2018 | Details |
| A14235 | 29511882 | Curr Atheroscler Rep | Cardiometabolic Effects of Anti-obesity Pharmacotherapy. | 2018 | Details |
| A14236 | 29511669 | Biomed Res Int | Ethanol Extract from Ulva prolifera Prevents High-Fat Diet-Induced Insulin Resistance, Oxidative Stress, and Inflammation Response in Mice. | 2018 | Details |
| A14240 | 29509436 | Am J Physiol Endocrinol Metab | Developmental origins of nonalcoholic fatty liver disease as a risk factor for exaggerated metabolic and cardiovascular-renal disease. | 2018 | Details |
| A14241 | 29508520 | Mol Nutr Food Res | Sugary Kefir Strain Lactobacillus mali APS1 Ameliorated Hepatic Steatosis by Regulation of SIRT-1/Nrf-2 and Gut Microbiota in Rats. | 2018 | Details |
| A14243 | 29507903 | Hepatol Commun | Insulin signaling as a potential natural killer cell checkpoint in fatty liver disease. | 2018 | Details |
| A14258 | 29499974 | Trends Pharmacol Sci | Specialized Proresolving Mediators: Enhancing Nonalcoholic Steatohepatitis and Fibrosis Resolution. | 2018 | Details |
| A14269 | 29491288 | Intern Med | A Patient with Non-alcoholic Steatohepatitis Complicated by Multiple Myeloma. | 2018 | Details |
| A14287 | 29482933 | Acta Histochem | Deletion of Thioredoxin-interacting protein ameliorates high fat diet-induced non-alcoholic steatohepatitis through modulation of Toll-like receptor 2-NLRP3-inflammasome axis: Histological and immunohistochemical study. | 2018 | Details |
| A14292 | 29479832 | Liver Int | Osteoporosis in chronic liver disease. | 2018 | Details |
| A14301 | 29474931 | Biochim Biophys Acta Mol Cell Biol Lipids | Alpha-syntrophin null mice are protected from non-alcoholic steatohepatitis in the methionine-choline-deficient diet model but not the atherogenic diet model. | 2018 | Details |
| A14306 | 29471595 | Diabetes Metab Res Rev | Procollagen-III peptide identifies adipose tissue-associated inflammation in type 2 diabetes with or without nonalcoholic liver disease. | 2018 | Details |
| A14317 | 29469051 | Ann Hepatol | Nonalcoholic Fatty Liver Disease Progresses into Severe NASH when Physiological Mechanisms of Tissue Homeostasis Collapse. | 2018 | Details |
| A14320 | 29467378 | Sci Rep | InForm software: a semi-automated research tool to identify presumptive human hepatic progenitor cells, and other histological features of pathological significance. | 2018 | Details |
| A14323 | 29466466 | PLoS One | Family history and obesity in youth, their effect on acylcarnitine/aminoacids metabolomics and non-alcoholic fatty liver disease (NAFLD). Structural equation modeling approach. | 2018 | Details |
| A14329 | 29463471 | EBioMedicine | IL-4 Receptor Alpha Signaling through Macrophages Differentially Regulates Liver Fibrosis Progression and Reversal. | 2018 | Details |
| A14330 | 29463133 | Arch Physiol Biochem | Effects of combined therapy with resveratrol, continuous and interval exercises on apoptosis, oxidative stress, and inflammatory biomarkers in the liver of old rats with non-alcoholic fatty liver disease. | 2018 | Details |
| A14332 | 29463024 | Int J Mol Sci | Overexpression of the Vitronectin V10 Subunit in Patients with Nonalcoholic Steatohepatitis: Implications for Noninvasive Diagnosis of NASH. | 2018 | Details |
| A14335 | 29462565 | Am J Physiol Endocrinol Metab | Pycnogenol protects against diet-induced hepatic steatosis in apolipoprotein-E-deficient mice. | 2018 | Details |
| A14337 | 29461236 | Georgian Med News | FEATURES OF EXCRETION OF MELATONIN IN URINE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND NON-ALCOHOLIC FATTY LIVER DISEASE WITH MANIFESTATIONS OF FIBROSIS AND ITS RELATIONSHIP WITH CERTAIN METABOLIC AND IMMUNOLOGICAL INDICATORS. | 2018 | Details |
| A14338 | 29459774 | Sci Rep | Nonylphenol aggravates non-alcoholic fatty liver disease in high sucrose-high fat diet-treated rats. | 2018 | Details |
| A14344 | 29454969 | Biochem Biophys Res Commun | JIP3 knockout protects mice against high fat diet-induced liver injury. | 2018 | Details |
| A14345 | 29454967 | Biochem Biophys Res Commun | SARM1 deletion restrains NAFLD induced by high fat diet (HFD) through reducing inflammation, oxidative stress and lipid accumulation. | 2018 | Details |
| A14349 | 29452601 | Cardiovasc Diabetol | Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study. | 2018 | Details |
| A14356 | 29450671 | Inflammopharmacology | Short-term treatment with metformin reduces hepatic lipid accumulation but induces liver inflammation in obese mice. | 2018 | Details |
| A14360 | 29448843 | Expert Opin Investig Drugs | Cenicriviroc for the treatment of non-alcoholic steatohepatitis and liver fibrosis. | 2018 | Details |
| A14361 | 29447962 | Int J Biol Macromol | Low molecular weight fucoidan attenuates liver injury via SIRT1/AMPK/PGC1α axis in db/db mice. | 2018 | Details |
| A14365 | 29445657 | Med J Islam Repub Iran | Correlation of visfatin level with non-alcoholic fatty liver in metabolic syndrome. | 2017 | Details |
| A14372 | 29441049 | Front Microbiol | Intestinal Microbiome Shifts, Dysbiosis, Inflammation, and Non-alcoholic Fatty Liver Disease. | 2018 | Details |
| A14382 | 29434731 | Exp Ther Med | Correlation between PPAR-α methylation level in peripheral blood and inflammatory factors of NAFLD patients with DM. | 2017 | Details |
| A14383 | 29434690 | Exp Ther Med | Changes in inflammatory factors and prognosis of patients complicated with non-alcoholic fatty liver disease undergoing coronary artery bypass grafting. | 2017 | Details |
| A14391 | 29430321 | Liver Res | Interaction between stress responses and circadian metabolism in metabolic disease. | 2017 | Details |
| A14394 | 29428719 | Biochem Biophys Res Commun | Combination effects of alogliptin and pioglitazone on steatosis and hepatic fibrosis formation in a mouse model of non-alcoholic steatohepatitis. | 2018 | Details |
| A14400 | 29427492 | Liver Int | Future therapy for non-alcoholic fatty liver disease. | 2018 | Details |
| A14411 | 29420066 | Am J Physiol Gastrointest Liver Physiol | CC chemokine receptor 2 promotes recruitment of myeloid cells associated with insulin resistance in nonalcoholic fatty liver disease. | 2018 | Details |
| A14413 | 29419350 | Ultrastruct Pathol | Swim exercise training ameliorates hepatocyte ultrastructural alterations in rats fed on a high fat and sugar diet. | 2018 | Details |
| A14424 | 29413959 | Redox Biol | Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: Current and innovative therapeutic approaches. | 2018 | Details |
| A14433 | 31294396 | J Can Assoc Gastroenterol | 2017 Canadian Association of Gastroenterology Educational Needs Assessment Report. | 2018 | Details |
| A14440 | 29406435 | Eur J Gastroenterol Hepatol | Diagnostic performance of a new noninvasive test for nonalcoholic steatohepatitis using a simplified histological reference. | 2018 | Details |
| A14444 | 29404514 | Hepatol Commun | Serine/threonine protein kinase 25 antisense oligonucleotide treatment reverses glucose intolerance, insulin resistance, and nonalcoholic fatty liver disease in mice. | 2017 | Details |
| A14453 | 29404440 | Hepatol Commun | Engineered FGF19 eliminates bile acid toxicity and lipotoxicity leading to resolution of steatohepatitis and fibrosis in mice. | 2017 | Details |
| A14455 | 29402900 | Sci Rep | Canagliflozin, an SGLT2 inhibitor, attenuates the development of hepatocellular carcinoma in a mouse model of human NASH. | 2018 | Details |
| A14458 | 29401710 | Nutrients | Dietary Iron Supplementation Alters Hepatic Inflammation in a Rat Model of Nonalcoholic Steatohepatitis. | 2018 | Details |
| A14467 | 29399273 | World J Hepatol | Role of inflammatory response in liver diseases: Therapeutic strategies. | 2018 | Details |
| A14468 | 29399077 | Exp Ther Med | Relationship between intestinal flora and inflammatory factors in patients with nonalcoholic steatohepatitis. | 2017 | Details |
| A14469 | 29398867 | World J Gastroenterol | Diet switch and omega-3 hydroxy-fatty acids display differential hepatoprotective effects in an obesity/nonalcoholic fatty liver disease model in mice. | 2018 | Details |
| A14495 | 29381809 | Hepatology | Tumor Progression Locus 2 in Hepatocytes Potentiates Both Liver and Systemic Metabolic Disorders in Mice. | 2018 | Details |
| A14509 | 29376983 | Zh Nevrol Psikhiatr Im S S Korsakova | [Antiinflammatory treatment in patients with chronic back pain]. | 2019 | Details |
| A14512 | 29375205 | World J Gastroenterol | INT-767 improves histopathological features in a diet-induced ob/ob mouse model of biopsy-confirmed non-alcoholic steatohepatitis. | 2018 | Details |
| A14516 | 29373070 | J Med Food | Lipolysis-Stimulating Peptide from Soybean Protects Against High Fat Diet-Induced Apoptosis in Skeletal Muscles. | 2018 | Details |
| A14518 | 29371998 | Toxicol Res | Protective Effect of Isoliquiritigenin against Ethanol-Induced Hepatic Steatosis by Regulating the SIRT1-AMPK Pathway. | 2018 | Details |
| A14519 | 29371918 | Oncotarget | Long-term administration of tacrolimus and everolimus prevents high cholesterol-high fructose-induced steatosis in C57BL/6J mice by inhibiting de-novo lipogenesis. | 2017 | Details |
| A14526 | 29367619 | Cell Death Dis | Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease. | 2018 | Details |
| A14529 | 29367207 | Gut | Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation. | 2018 | Details |
| A14536 | 29364090 | Acta Gastroenterol Belg | Serum concentrations of Cyclophilin A in patients with Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A14537 | 29363914 | Pol J Pathol | Expression of resistin in the liver of patients with non-alcoholic fatty liver disease. | 2018 | Details |
| A14552 | 29357809 | Cardiovasc Hematol Agents Med Chem | Coagonist of GLP-1 and Glucagon Receptor Ameliorates Development of Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
| A14559 | 29354946 | Zhongguo Zhen Jiu | [Mechanisms of acupuncture for non-alcoholic fatty liver disease: researches progress and prospects]. | 2018 | Details |
| A14561 | 29353414 | Probiotics Antimicrob Proteins | Oral Administration of Compound Probiotics Ameliorates HFD-Induced Gut Microbe Dysbiosis and Chronic Metabolic Inflammation via the G Protein-Coupled Receptor 43 in Non-alcoholic Fatty Liver Disease Rats. | 2019 | Details |
| A14580 | 29342107 | Molecules | Honokiol Improves Liver Steatosis in Ovariectomized Mice. | 2018 | Details |
| A14582 | 29341349 | Pathol Int | Peroxiredoxin 4 (PRDX4): Its critical in vivo roles in animal models of metabolic syndrome ranging from atherosclerosis to nonalcoholic fatty liver disease. | 2018 | Details |
| A14591 | 29335857 | Chin J Integr Med | Effect of Soothing Gan (Liver) and Invigorating Pi (Spleen) Recipes on TLR4-p38 MAPK Pathway in Kupffer Cells of Non-alcoholic Steatohepatitis Rats. | 2018 | Details |
| A14592 | 29335425 | Sci Rep | SPARC expression is associated with hepatic injury in rodents and humans with non-alcoholic fatty liver disease. | 2018 | Details |
| A14600 | 29330220 | Drug Metab Dispos | Regulation of Drug Metabolism by the Interplay of Inflammatory Signaling, Steatosis, and Xeno-Sensing Receptors in HepaRG Cells. | 2018 | Details |
| A14603 | 29328026 | Georgian Med News | CLINICAL EFFICACY OF S-ADENOSYLMETHIONINE IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS AND CHRONIC KIDNEY DISEASE I-II STAGE. | 2017 | Details |
| A14609 | 29325294 | Zhonghua Gan Zang Bing Za Zhi | [Effects of Lactobacillus paracasei N1115 combined with fructooligosaccharides on non-alcoholic fatty liver disease induced by high-fat diet in mice]. | 2017 | Details |
| A14631 | 29315766 | Hepatology | Disruption of adenosine 2A receptor exacerbates NAFLD through increasing inflammatory responses and SREBP1c activity. | 2018 | Details |
| A14642 | 29311481 | Biol Pharm Bull | A PPAR Pan Agonist, MHY2013 Alleviates Age-Related Hepatic Lipid Accumulation by Promoting Fatty Acid Oxidation and Suppressing Inflammation. | 2018 | Details |
| A14664 | 29299197 | Iran J Basic Med Sci | Inhibition of 5-lipoxygenase inhibitor zileuton in high-fat diet-induced nonalcoholic fatty liver disease progression model. | 2017 | Details |
| A14665 | 29298969 | Pol Merkur Lekarski | [Dietetary recommendation for non-alcoholic fatty liver disease]. | 2017 | Details |
| A14667 | 29298863 | FASEB J | Dual regulation of HMGB1 by combined JNK1/2-ATF2 axis with miR-200 family in nonalcoholic steatohepatitis in mice. | 2018 | Details |
| A14668 | 29295869 | Endocr Connect | Macrophage activation marker sCD163 correlates with accelerated lipolysis following LPS exposure: a human-randomised clinical trial. | 2018 | Details |
| A14670 | 29294265 | Postepy Biochem | [The role of NOD-like receptors (NLRs) in the pathogenesis of metabolic diseases]. | 2019 | Details |
| A14671 | 29294263 | Postepy Biochem | [NAFLD pathogenesis in the light of recent research]. | 2019 | Details |
| A14687 | 30853754 | Trends Cell Mol Biol | Upregulation of non-canonical Wnt ligands and oxidative glucose metabolism in NASH induced by methionine-choline deficient diet. | 2018 | Details |